Melittin-Mil-2 Fusion Protein as a Candidate for Cancer Immunotherapy

Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-016-0910-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeted IL-15-based Protein Fusion Complexes as Cancer Immunotherapy Approaches

Journal of Immunological Sciences
2018English

Ring Finger Protein 43 as a New Target for Cancer Immunotherapy

Clinical Cancer Research
Cancer ResearchOncology
2004English

Fusion Protein, DNAJB1-PRKACA, as a Cancer Driver

Biophysical Journal
Biophysics
2017English

PASD1, a DLBCL-associated Cancer Testis Antigen and Candidate for Lymphoma Immunotherapy

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Design of Split Superantigen Fusion Proteins for Cancer Immunotherapy

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2019English

Aptamers as a Promising Therapeutic Tool for Cancer Immunotherapy

2017English

Radiotherapy as a Backbone for Novel Concepts in Cancer Immunotherapy

Cancers
Cancer ResearchOncology
2019English

ICOS-L as a Potential Therapeutic Target for Cancer Immunotherapy

Current Protein and Peptide Science
MedicineBiochemistryCell BiologyMolecular Biology
2018English

Lipoprotein Lipase as a Candidate Target for Cancer Prevention/Therapy

Biochemistry Research International
Biochemistry
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy